# medac GmbH clinical trials: 22 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials with medac GmbH as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by medac GmbH: 22 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/medac-gmbh

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 2, 2024 | NCT06239311 | Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis. | medac GmbH | Phase 3 | Recruiting | Moderate to Severe Atopic Dermatitis | 277 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06239311) |
| October 10, 2023 | NCT06075706 | Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease | medac GmbH | Phase 2 | Active not recruiting | Steroid-refractory Acute Graft-versus-host Disease | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06075706) |
| September 9, 2022 | NCT05534620 | Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics | medac GmbH | Phase 1 | Completed | Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05534620) |
| November 16, 2020 | NCT04629833 | Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy | medac GmbH | Phase 3 | Recruiting | Steroid-refractory Acute Graft-versus-host Disease | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04629833) |
| May 17, 2017 | NCT03156790 | PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia | medac GmbH | Phase 2 | Terminated | Acute B-Cell Lymphoblastic Leukaemia | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03156790) |
| April 28, 2016 | NCT02755142 | Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas | medac GmbH | Phase 1/2 | Completed | Brain Neoplasm | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02755142) |
| January 29, 2015 | NCT02349906 | Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases | medac GmbH | Phase 2 | Completed | Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies, Bone Marrow Failure Syndromes | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02349906) |
| January 7, 2015 | NCT02333058 | Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies | medac GmbH | Phase 2 | Completed | Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS), Juvenile... | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02333058) |
| March 26, 2014 | NCT02097173 | Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen | medac GmbH | Phase 1 | Completed | Psoriasis | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02097173) |
| January 31, 2014 | NCT02052167 | Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis | medac GmbH | Early phase 1 | Completed | Juvenile Idiopathic Arthritis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02052167) |
| June 7, 2013 | NCT01871961 | Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient | medac GmbH | Phase 1 | Completed | Rheumatoid Arthritis (RA) | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01871961) |
| February 15, 2013 | NCT01793259 | Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA) | medac GmbH | Phase 3 | Completed | Rheumatoid Arthritis | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01793259) |
| December 2, 2010 | NCT01251809 | Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic... | medac GmbH | Phase 1/2 | Terminated | Acute Lymphoblastic Leukaemia | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01251809) |
| February 5, 2010 | NCT01063660 | Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML) | medac GmbH | Phase 2 | Completed | Acute Myeloid Leukaemia | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01063660) |
| February 5, 2010 | NCT01063647 | Dose-range Finding Treosulfan-based Conditioning | medac GmbH | Phase 1/2 | Completed | Hematological Malignancies | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01063647) |
| February 4, 2010 | NCT01062490 | Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS) | medac GmbH | Phase 2 | Completed | Myelodysplastic Syndrome | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01062490) |
| September 23, 2009 | NCT00983138 | Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL) | medac GmbH | Phase 2 | Completed | Acute Lymphoid Leukemia | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00983138) |
| January 15, 2009 | NCT00823225 | Urokinase Therapy in Patients With Diabetic Foot Syndrome | medac GmbH | Phase 3 | Terminated | Diabetic Foot, Arterial Occlusive Disease, Ischemia | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00823225) |
| January 14, 2009 | NCT00822393 | Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC) | medac GmbH | Phase 3 | Completed | Acute Myeloid Leukemia, Myelodysplastic Syndrome | 570 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00822393) |
| November 3, 2008 | NCT00784017 | Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia | medac GmbH | Phase 3 | Completed | Acute Lymphoblastic Leukemia | 199 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00784017) |
| October 1, 2007 | NCT00537498 | Urokinase Therapy in Diabetic Foot Syndrome | medac GmbH | Phase 2 | Completed | Diabetic Foot, Arterial Occlusive Disease, Ischemia | 77 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00537498) |
| October 19, 2005 | NCT00241670 | Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid | medac GmbH | Phase 3 | Completed | Brain Cancer, Brain Tumors, Cancer of Brain, Primary Brain Tumors, Brain Tumor, Primary | 415 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00241670) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 3 |
| Phase 1/2 | 3 |
| Phase 2 | 8 |
| Phase 3 | 7 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 16 |
| Terminated | 3 |
| Recruiting | 2 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Myelodysplastic Syndromes | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Leukemia, Myeloid, Acute | 3 |
| Brain Neoplasms | 2 |
| Arthritis, Rheumatoid | 2 |
| Diabetic Foot | 2 |
| Arterial Occlusive Diseases | 2 |
| Ischemia | 2 |
| Diabetes Mellitus | 2 |
| Psoriasis | 1 |
| Leukemia | 1 |
| Arthritis, Juvenile | 1 |
| Hematologic Neoplasms | 1 |
| Metabolism, Inborn Errors | 1 |
| Hemoglobinopathies | 1 |
| Bone Marrow Failure Disorders | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Mongolian restaurants in the United States](https://specstream.ai/data/businesses/mongolian-restaurants/united-states)
- [Vehicle manufacturers in the United States](https://specstream.ai/data/businesses/vehicle-manufacturers/united-states)
- [Dentistry schools in the United States](https://specstream.ai/data/businesses/dentistry-schools/united-states)
- [Medical supply stores in the United States](https://specstream.ai/data/businesses/medical-supply-stores/united-states)
- [Truck repair shops in the United States](https://specstream.ai/data/businesses/truck-repair-shops/united-states)
- [Credit and debt counseling services in the United States](https://specstream.ai/data/businesses/credit-and-debt-counseling-services/united-states)
